- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05346016
The PEARL-AGE Study. Multigenerational Gut Bacteria Transmission and Its Stability in Families.
Multigenerational Gut Bacteria Transmission and Its Stability in Families
Study Overview
Status
Conditions
Detailed Description
Interest in the gut microbiome from both the scientific community and public has increased exponentially over the last decade. Yet our knowledge of the microbes in the gut microbiome, their persistence and dispersal to new human hosts is still surprisingly ill-defined.
Investigators hypothesize that some gut microbes persist over multiple generations and are adapted to varying degrees to their human hosts and families, making them potentially important members of the human gut. Bacterial strains can persist in the human host for years, with maternally-transferred strains known to persist longer in infants than environmentally acquired ones. It is conceivable that a given strain can colonize a host for several vertical generations, as already shown for Bifidobacterium using cultured isolates. Yet investigators currently lack knowledge of microbial persistence over multiple generations, and the proposed PEARL-AGE cohort is the first study investigating multi-generation persistence of gut bacteria (to our best knowledge).
The PEARL-AGE project will investigate microbial transfer and the evolution of microbes in family members from different generations. Investigators will recruit siblings, fathers/guardians, grandparents, and great-grandparents to fully capture vertical (between generations) and horizontal (same generation) microbial transmission across multiple generations, as well as tracking parallel microbial evolution in multiple family members. This will substantially increase our understanding of microbial transmission, long-term microbial persistence through generations and between cohabiting family members and siblings.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
Norfolk
-
Norwich, Norfolk, United Kingdom, NR4 7UQ
- Quadram Institute Biosciences
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
The following relations of the PEARL mother/baby are eligible for inclusion:
- Husband/partner of a PEARL mother, their biological parents and grandparents.
- PEARL mother's biological parents and grandparents (great-grandparents to the PEARL baby).
- Co-habiting non-biological fathers of the baby such as stepfathers and partners of the PEARL mother, their parents and grandparents.
- A biological sibling of the PEARL baby or a step-sibling who is currently co-habiting with the PEARL baby.
- Adult participants must be able to consent for themselves and able to understand the questionnaire.
- Child participants must have a parent and/or guardian to provide assent on their behalf.
- Must be living in England.
- Must be willing to accommodate a small cool box to store and transport the biological samples until they are collected, if not having immediate access to the PEARL study freezer.
- Vulnerable participants such as participants with mild cognitive impairment may be included as long as they have full support from their family members.
Exclusion Criteria:
- Not related/affiliated to a mother currently participating in the PEARL study, or the cohabiting partner, or father of the PEARL infant. If a PEARL participant has withdrawn from the PEARL study or is no longer participating, investigators will not approach the PEARL participant for recruitment of their family members.
- Step-fathers or long-term partners that have been cohabiting with the PEARL mother for less than three months.
- Those currently in prison.
- Those who are unable to provide written informed consent.
- Living with or related to a member of the Research Study team.
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Characterizing microbial transfers in multigenerational families and subsequent stability of microbial colonization.
Time Frame: 2026
|
High-resolution metagenomics of strains tracked over time in individuals and families, relative to collected metadata (family closeness, medical history, etc) Associating microbiome stability to human genetic loci.
|
2026
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Characterizing gut microbial evolution and adaptation in human host families.
Time Frame: 2026
|
Comparative genomics of metagenome assembled genomes (MAGs) per individual. Identifying newly introduced mutations in microbial genomes. Observing parallel evolution (e.g., loss or gain of the same genes in bacteria). Associating human genotypes to microbial adaptation. |
2026
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Describing the prokaryotic and eukaryotic genome-level diversity within the human gut
Time Frame: 2024
|
Newly developed DNA extraction protocols for enrichment of specific microbial clades.
|
2024
|
|
Identify predictors of within-family gut microbe transfer rates
Time Frame: 2026
|
Correlation coefficient of collected metadata (questionnaire derived) to observed shared microbes Correlate parallel colonization's of sibling to family questionnaire metadata (e.g.
distances, closeness, habits, ..) Correlate genetic factors (immune system, etc) to microbial sharing/colonization rates
|
2026
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Falk Hildebrand, PhD, Quadram Institute Bioscience
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- QIB01-2021
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Family Research
-
The University of Hong KongTung Wah Group of HospitalsCompletedParenting | Family | Family Research
-
The University of Hong KongNot yet recruiting
-
The University of Hong KongThe Hong Kong Jockey Club Charities TrustRecruiting
-
Brigham and Women's HospitalCompletedHealth Status | Family Research | Family CharacteristicsUnited States
-
Clinica Universidad de Navarra, Universidad de...Completed
-
Boston CollegeCompleted
-
Reproductive Medicine Associates of New JerseyCompleted
-
The University of Hong KongThe Hong Kong Jockey Club Charities TrustRecruiting
-
Clinica Universidad de Navarra, Universidad de...CompletedFamily ResearchSpain
-
NYU Langone HealthEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruiting